Pink SheetVanda Pharmaceuticals added to its dubious accomplishment as the US Food and Drug Administration’s most oppositional sponsor with a multi-front defense of its gastroparesis candidate tradipitant foll
Pink SheetUS Food and Drug Administration Principal Deputy Commissioner Namandjé Bumpus’ decision to leave by the end of the year means there is no obvious, internal candidate to serve as acting commissioner in
HBW InsightUS Food and Drug Administration Principal Deputy Commissioner Namandjé Bumpus’ decision to leave by the end of the year means there is no obvious, internal candidate to serve as acting commissioner in
Medtech InsightUS Food and Drug Administration Principal Deputy Commissioner Namandjé Bumpus’ decision to leave by the end of the year means there is no obvious internal candidate to serve as acting commissioner in